(Q33344882)

26 July 2017

1 reference

title

Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle (English)

1 reference

26 July 2017

1 reference

Daniele Santini

2

0 references

author name string

Francesco Bertoldo

series ordinal

1

1 reference

26 July 2017

Vincenzo Lo Cascio

series ordinal

3

1 reference

26 July 2017

publication date

1 December 2007

1 reference

Nature Clinical Practice Oncology

26 July 2017

published in

1 reference

26 July 2017

volume

4

1 reference

26 July 2017

issue

12

1 reference

26 July 2017

page(s)

711-721

1 reference

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Ultrastructural and histochemical examination of alveolar bone at the pressure areas of rat molars submitted to continuous orthodontic force

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteoclast recruitment to sites of compression in orthodontic tooth movement

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bone wound healing after maxillary molar extraction in ovariectomized aged rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Cellular origins and differentiation control mechanisms during periodontal development and wound healing

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Role of osteopontin in bone remodeling caused by mechanical stress

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Periodontal disease and the incidence of tooth loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Alveolar bone levels in adults as assessed on panoramic radiographs. (I) Prevalence, extent, and severity of even and angular bone loss

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Current perspectives in residual ridge remodeling and its clinical implications: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Recent advances in understanding the mechanism of action of bisphosphonates

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bisphosphonate actions: physical chemistry revisited

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

New Insights Into the Molecular Mechanisms of Action of Bisphosphonates

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Molecular mechanisms of action of bisphosphonates: current status.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Fracture risk remains reduced one year after discontinuation of risedronate

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronate

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Relationships Between Pharmacokinetics and Rate of Bone Turnover After Intravenous Bisphosphonate (Olpadronate) in Patients With Paget's Disease of Bone

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

The effect of alendronate on resorption of the alveolar bone following tooth extraction

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteoclastic activity begins early and increases over the course of bone healing.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Growth factors for bone growth and repair: IGF, TGF beta and BMP.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Spatial and temporal localization of transforming growth factor-beta1, bone morphogenetic protein-2, and platelet-derived growth factor-A in healing tooth extraction sockets in a rabbit model

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Increase of transforming growth factor-beta 1 in gingival crevicular fluid during human orthodontic tooth movement

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Insulin-like growth factor system components in the periodontium during tooth root resorption and early repair processes in the rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Zoledronic acid improves the mechanical properties of normal and healing bone

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteonecrosis of the maxilla as a complication to chemotherapy: a case report.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

New foundations in understanding osteonecrosis of the jaws

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Efficacy of pamidronate in complex regional pain syndrome type I.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Prevention and management of oral infections in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Periodontal infection in cancer patients treated with high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Actinobacillus actinomycetemcomitans lipopolysaccharide activates matrix metalloproteinase-2 and increases receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Classifications of oral lesions in HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Ibandronate: a clinical pharmacological and pharmacokinetic update

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Studies of the oral bioavailability of alendronate.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bisphosphonates in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Osteonecrosis of the jaw--do bisphosphonates pose a risk?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Transmission of human herpesvirus 8 by blood transfusion

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Bone resorption predicts for skeletal complications in metastatic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1000

7 January 2021

Identifiers

DOI

10.1038/NCPONC1000

1 reference

release_5i3kpgs6engsblokt3x7hb3gt4

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5i3kpgs6engsblokt3x7hb3gt4

24 November 2022

mapped directly with Wikidata item

1 reference